Skip to content

Clinical trials

Completed Phase 4 Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 4 Status: Completed Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20039
20047
20058
20068
20075
20087
20095
20105
20112
20124
20132
20143
20152
20163
20171
20183
20195
20201
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.11
Novartis5
Takeda5
Yonsei University4
Novartis Pharmaceuticals3
Radiant Research2
Sanofi2
Seoul National University Hospital2
Washington University School of Medicine2
Yuhan Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias87
Diabetes Mellitus, Type 219
Hypertension16
Diabetes Mellitus12
Hypercholesterolemia11
Glucose Metabolism Disorders7
HIV Infections7
Cardiovascular Diseases6
Hyperlipidemias6
Atherosclerosis5

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.